Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12>>>
35 Items
Title  Creator  Group name  Publishing year 
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches Abba Moussa et al. EquipePM 2025-12
Multi-step semi-synthesis, structural characterization and growth factor interaction study of regiochemically sulfated diabolican polysaccharides Esposito et al. PlateformePP2I 2024-03
Generation of non-genetically modified, CAR-like, NK cells Coënon et al. EquipePM 2024-07-18
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import Boulay et al. PlateformePP2I 2024-11
Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods Dumet et al. PlateformePP2I 2023-03-16
Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain Tassou et al. EquipePM 2023-01-13
A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity Schatz et al. PlateformePP2I 2023-04-27
A bioinspired approach for the modulation of electroosmotic flow and protein-surface interactions in capillary electrophoresis using silylated amino-amides blocks and covalent grafting Gouyon et al. PlateformePP2I 2023-12-31
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition Billiald et al. PlateformePP2I 2022-11-14
New recognition specificity in a plant immune receptor by molecular engineering of its integrated domain Cesari et al. PlateformePP2I 2022-03-21
Development of Amino Acids Functionalized SBA-15 for the Improvement of Protein Adsorption Gutiérrez-Climente et al. PlateformePP2I 2021-10-08
Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex Bailly et al. PlateformePP2I 2021-05-25
Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences Cnudde et al. PlateformePP2I Apr 15, 2020
Alterins Produced by Oyster-Associated Pseudoalteromonas Are Antibacterial Cyclolipopeptides with LPS-Binding Activity Desriac et al. PlateformePP2I 2020-12-10
4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis Granel et al. PlateformePP2I 2020
Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating Fernandez et al. PlateformePP2I Nov 2019
Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model Chauvin et al. PlateformePP2I 2019
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies Ashraf et al. EquipeAT Feb 04, 2019
CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis Knabe et al. PlateformePP2I 2019-04-25
Binding analysis between monomeric ?-casein and hydrophobic bioactive compounds investigated by surface plasmon resonance and fluorescence spectroscopy Bahri et al. PlateformePP2I Jul 15, 2019
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions Neiveyans et al. PlateformeIPAM 2019-04-03
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer Ogier et al. EquipeAP 09 28, 2018
PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28? Jonik-Nowak et al. PlateformePP2I 07 10, 2018
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells Chopard et al. PlateformePP2I 06 08, 2018
Thrombospondin-1 (TSP-1), a new bone morphogenetic protein-2 and -4 (BMP-2/4) antagonist identified in pituitary cells Sallon et al. PlateformePP2I 09 15, 2017
12>>>
35 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés